XML 54 R43.htm IDEA: XBRL DOCUMENT v3.25.3
STOCKHOLDERS' EQUITY - Activity in stockholders' equity (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
USD ($)
shares
Jun. 30, 2025
USD ($)
shares
Mar. 31, 2025
USD ($)
shares
Sep. 30, 2024
USD ($)
shares
Jun. 30, 2024
USD ($)
shares
Mar. 31, 2024
USD ($)
shares
Sep. 30, 2025
USD ($)
shares
Sep. 30, 2024
USD ($)
shares
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning Balance (in shares) | shares     1,035,893       1,035,893  
Beginning Balance $ 6,977 $ 2,892 $ 2,511 $ 3,114 $ 4,610 $ 6,351 $ 2,511 $ 6,351
Stock-based compensation 47 90 91 73 88 85    
Issuance of common stock, net of transaction costs   $ 1,640 1,066          
Issuance of common stock upon exercise of warrants (in shares) | shares   40,000            
Issuance of common stock upon exercise of warrants, net of transaction costs 5,622 $ 3,971 889 1,977   6    
Net loss $ (1,298) (1,616) (1,665) (1,513) (1,584) (1,832) $ (4,579) (4,929)
Ending Balance (in shares) | shares 5,223,015           5,223,015  
Ending Balance $ 11,348 $ 6,977 $ 2,892 $ 3,651 $ 3,114 $ 4,610 $ 11,348 $ 3,651
Stock split, conversion ratio       0.10        
Common Stock                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning Balance (in shares) | shares 3,764,143 1,775,930 1,035,893 515,340 514,463 514,003 1,035,893 514,003
Beginning Balance $ 4 $ 2 $ 1 $ 1 $ 1 $ 1 $ 1 $ 1
Issuance of common stock, net of issuance costs (in shares) | shares   489,341 365,319       854,660  
Issuance of common stock, net of transaction costs   $ 1            
Issuance of common stock upon exercise of warrants (in shares) | shares 1,458,872 1,498,872 374,718 505,502   460    
Issuance of common stock upon exercise of warrants, net of transaction costs $ 1 $ 1 $ 1          
Issuance of common stock for fractional shares in the 10:1 reverse stock split (in shares) | shares         877      
Ending Balance (in shares) | shares 5,223,015 3,764,143 1,775,930 1,020,842 515,340 514,463 5,223,015 1,020,842
Ending Balance $ 5 $ 4 $ 2 $ 1 $ 1 $ 1 $ 5 $ 1
Additional Paid-In Capital                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning Balance 146,351 140,652 138,607 136,442 136,354 136,263 138,607 136,263
Stock-based compensation 47 90 91 73 88 85    
Issuance of common stock, net of transaction costs   1,639 1,066          
Issuance of common stock upon exercise of warrants, net of transaction costs 5,621 3,970 888 1,977   6    
Ending Balance 152,019 146,351 140,652 138,492 136,442 136,354 152,019 138,492
Accumulated Deficit                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning Balance (139,378) (137,762) (136,097) (133,329) (131,745) (129,913) (136,097) (129,913)
Net loss (1,298) (1,616) (1,665) (1,513) (1,584) (1,832)    
Ending Balance $ (140,676) $ (139,378) $ (137,762) $ (134,842) $ (133,329) $ (131,745) $ (140,676) $ (134,842)